[1] |
Tsukamoto S, Ishikawa T, Iida S, et al. Clinical significance of osteoprotegerin expression in human colorectal cancer[J]. Clin Cancer Res, 2011, 17:2444-2450.
|
[2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71:209-249.
|
[3] |
Benedit P, Paciucci R, Thomson TM, et al. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks[J]. Oncogene, 2001, 20:1455-1464.
|
[4] |
Lei F, Zhang L, Li X, et al. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer[J]. BMC Cancer, 2014, 14:457. doi:10.1186/1471-2407-14-457.
|
[5] |
Sinicrope FA. Increasing incidence of early-onset colorectal cancer[J]. N Engl J Med, 2022, 386:1547-1558.
|
[6] |
Shen H, Liao B, Wan Z, et al. PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer[J]. Mol Ther Oncolytics, 2021, 20:499-507.
|
[7] |
Wu Z, Liu Z, Jiang X, et al. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits[J]. J Exp Clin Cancer Res, 2019, 38:341. doi:10.1186/s13046-019-1349-y.
|
[8] |
Karna SKL, Ahmad F, Lone BA, et al. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells[J]. PLoS One, 2019, 14:e0211658. doi:10.1371/journal.pone.0211658.
|
[9] |
Morote J, Fernandez S, Alana L, et al. PTOV1 expres-sion predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy[J]. Clin Cancer Res, 2008, 14:2617-2622. doi:10.1158/1078-0432.CCR-07-4987.
|
[10] |
Pennington KL, McEwan CM, Woods J, et al. SGK2, 14-3-3, and HUWE1 cooperate to control the localization, stability, and function of the oncoprotein PTOV1[J]. Mol Cancer Res, 2022, 20:231-243.
|
[11] |
Santamaria A, Castellanos E, Gomez V, et al. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts[J]. Mol Cell Biol, 2005, 25:1900-1911.
|
[12] |
Marques N, Sese M, Canovas V, et al. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1[J]. Oncogene, 2014, 33:1124-1134.
|